• Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry

  • Aug 26 2023
  • Length: 55 mins
  • Podcast
Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry cover art

Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry

  • Summary

  • "Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape"

    The "Psychedelics Capital Podcast" host Ross O'Brien  from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscape for psychedelics. Michael, a partner at the law firm, explains that while the FDA sees itself as a public health agency focused on ensuring safe and effective products, the DEA approaches controlled substances like psychedelics from a law enforcement perspective due to their potential dangers. He highlights that while many drugs, including psychedelics, have potential benefits, the FDA emphasizes the importance of rigorous clinical trials to establish their safety and efficacy, particularly in a landscape where recreational and unregulated use is also prevalent.

     

    Produced by PodConx

    Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

    Bonaventure Equity - https://link.bve.vc/Visit-Us

    Michael Warner - https://www.linkedin.com/in/michael-werner-a402189/

    Holland & Knight - https://www.hklaw.com/

    Show More Show Less

What listeners say about Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.